An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation

Michelle S. Miller, Jacqueline Douglass, Michael S. Hwang, Andrew D. Skora, Michael Murphy, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B. Gabelli

Open source

DOI: 10.1074/jbc.ra119.010251
Published: 2019-12
Container: Journal of Biological Chemistry
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1074/jbc.ra119.010251,
  title = {An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation},
  author = {Michelle S. Miller and Jacqueline Douglass and Michael S. Hwang and Andrew D. Skora and Michael Murphy and Nickolas Papadopoulos and Kenneth W. Kinzler and Bert Vogelstein and Shibin Zhou and Sandra B. Gabelli},
  year = {2019},
  journal = {Journal of Biological Chemistry},
  doi = {10.1074/jbc.ra119.010251},
  url = {https://doi.org/10.1074/jbc.ra119.010251}
}

RIS

TY  - JOUR
TI  - An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
AU  - Michelle S. Miller
AU  - Jacqueline Douglass
AU  - Michael S. Hwang
AU  - Andrew D. Skora
AU  - Michael Murphy
AU  - Nickolas Papadopoulos
AU  - Kenneth W. Kinzler
AU  - Bert Vogelstein
AU  - Shibin Zhou
AU  - Sandra B. Gabelli
PY  - 2019
JO  - Journal of Biological Chemistry
DO  - 10.1074/jbc.ra119.010251
UR  - https://doi.org/10.1074/jbc.ra119.010251
ER  -

APA

Miller, M. S., Douglass, J., Hwang, M. S., Skora, A. D., Murphy, M., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Zhou, S., & Gabelli, S. B. (2019). An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.ra119.010251

Source records

crossref · retrieved 2026-09-26T13:50:27.078Z